Epigenetic Regulatory Networks in Cancer: Understanding the Mechanisms of Disease Progression

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: 15 June 2025 | Viewed by 427

Special Issue Editors


E-Mail Website
Guest Editor
Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA
Interests: cancer; cell signaling; epigenetics; microRNA; targeted therapy; carcinogenesis; apoptosis
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Center for Cancer Researcg, National Cancer Institute, NIH, Bethesda, MD 20982, USA
Interests: cancer biology; stem cell research; iPSCs; epigenetics; immunotherapy; gene regulation; chromatin remodeling; drug discovery

Special Issue Information

Dear Colleagues,

Cancer remains a significant clinical challenge due to its aggressive nature, treatment resistance, and the complexity of its underlying mechanisms. Despite advancements in understanding cancer pathogenesis, many forms of cancer continue to have poor prognoses and limited therapeutic options. Recent studies have highlighted the critical role of epigenetic regulatory mechanisms in the development and progression of various cancers. This Special Issue aims to explore the intricate epigenetic landscape that governs cancer pathogenesis, focusing on key components such as DNA methylation, histone modifications, non-coding RNAs—including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs)—and chromatin remodeling. These factors play a crucial role in regulating gene expression and cellular behavior, contributing to the initiation and advancement of cancer.

This Special Issue will highlight recent advancements in epigenetic research, focusing on novel biomarkers for early detection and potential therapeutic targets that could lead to more effective and personalized treatment strategies. By integrating these insights, the research presented here holds the potential to improve patient outcomes and offer new avenues in the fight against cancer. Additionally, it will enhance the understanding of how epigenetic alterations impact cancer biology, potentially informing strategies against a wide range of malignancies. We welcome submissions ranging from basic research to translational studies, aiming to provide a comprehensive overview of the epigenetic regulatory networks involved in cancer.

Dr. Anand Singh
Dr. Sudheer Kumar Gara
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • cancer
  • epigenetics
  • miRNAs
  • BAP1
  • DNMTs
  • tumor suppressor
  • oncogenes
  • histone modification
  • chromatin remodeling

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop